Chr. Hansen results beat expectations, colours providing improved ROI 11-Jan-2012 By Jane Byrne Chr. Hansen’s first quarter results for financial year 2011/12 are a notch stronger than analysts had expected.
Chr. Hansen claims 'solid performance' allows hike in R&D investments 03-Nov-2011 By Jane Byrne Chr. Hansen’s full-year results are in line with expectations, says an analyst, but positives noted were the suppliers’ expectations for its EBIT margin growth and the better performance for its probiotics division in Q4.